Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotype

Haemophilia

Volumn 21, Issue 1, 2015, Pages 124-132

  Zia, A N ^a   Chitlur, M ^b   Rajpurkar, M ^b   Ozgonenel, B ^b   Lusher, J ^b   Callaghan, J H ^c   Callaghan, M U ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

Bleeding phenotype; Global coagulation assays; Inherited coagulation disorders

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 7; HIGH MOLECULAR WEIGHT KININOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN COMPLEX; VITAMIN K GROUP;

ADOLESCENT; ARTICLE; BERNARD SOULIER DISEASE; BLEEDING DISORDER; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 12 DEFICIENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BRAIN HEMORRHAGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSFIBRINOGENEMIA; EPISTAXIS; FEMALE; FIBRINOGEN DEFECT; FIBRINOLYSIS; HUMAN; MALE; PHENOTYPE; POSTOPERATIVE HEMORRHAGE; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY; RARE BLEEDING DISORDER; SCREENING TEST; THROMBOCYTE DISORDER; THROMBOELASTOGRAPHY; THROMBUS; BLEEDING; BLOOD; BLOOD CLOTTING TEST; BLOOD COAGULATION DISORDERS; INFANT; PRESCHOOL CHILD; PROCEDURES; RARE DISEASE; RETROSPECTIVE STUDY;

ADOLESCENT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMORRHAGE; HUMANS; INFANT; MALE; PHENOTYPE; RARE DISEASES; RETROSPECTIVE STUDIES; THROMBELASTOGRAPHY;

EID: 84921489377     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12481     Document Type: Article

References (17)

1. Shapiro AD, Soucie JM, Peyvandi F, Aschman DJ, DiMichele DM. Knowledge and therapeutic gaps: a public health problem in the rare coagulation disorders population. Am J Prev Med 2011; 41: S324-31.
2. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-52.
3. Borhany M, Pahore Z, Ul QZ et al. Bleeding disorders in the tribe: result of consanguineous in breeding. Orphanet J Rare Dis 2010; 5: 23.
4. Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005; 93: 481-7.
5. Bolton-Maggs PH. The rare inherited coagulation disorders. Pediatr Blood Cancer 2013; 60(Suppl 1): S37-40.
6. Revel-Vilk S. Clinical and laboratory assessment of the bleeding pediatric patient. Semin Thromb Hemost 2011; 37: 756-62.
7. Hartert H. Clinical studies on blood coagulation with thrombelastography. IV. Vascular hemorrhagic diatheses; bleedings without hemorrhagic diatheses; differential diagnosis of diatheses. Dtsch Arch Klin Med 1952; 199: 414-22.
8. Chitlur M. Challenges in the laboratory analyses of bleeding disorders. Thromb Res 2012; 130: 1-6.
9. Zekavat OR, Haghpanah S, Dehghani J, Afrasiabi A, Peyvandi F, Karimi M. Comparison of thrombin generation assay with conventional coagulation tests in evaluation of bleeding risk in patients with rare bleeding disorders. Clin Appl Thromb Hemost 2013; 6: s324-s331.
10. Van Geffen GM, Menegatti M, Loof A et al. Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders. Haemophilia 2012; 18: 630-8.
11. Castellino FJ, Liang Z, Davis PK et al. Abnormal whole blood thrombi in humans with inherited platelet receptor defects. PLoS ONE 2012; 7: e52878.
12. Peyvandi F. Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency. Thromb Res 2009; 124(Suppl 2): S9-11.
13. Dargaud Y, de Mazancourt P, Rugeri L et al. An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy. Blood Coagul Fibrinolysis 2008; 19: 447-52.
14. Chitlur M, Warrier I, Rajpurkar M et al. Thromboelastography in children with coagulation factor deficiencies. Br J Haematol 2008; 142: 250-6.
15. Kupesiz A, Rajpurkar M, Warrier I et al. Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography. Blood Coagul Fibrinolysis 2010; 21: 320-4.
16. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-8.
17. Jambor C, Reul V, Schnider TW et al. In vitro inhibition of FXIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood. Anesth Analg 2003; 109(4): 1023-8.